United States & Merck Group
12 shared events · Importance 7 · Last updated Aug 23, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Domestic
United States: The U.S. faces a measles outbreak and declining vaccination rates. The executive order could worsen public health outcomes and create international concern about vaccine policy.
Merck Group: Merck, the sole U.S. manufacturer of the MMR vaccine, stated it cannot produce separate shots for at least 10 years. The executive order could create regulatory and market uncertainty, though current sales are unaffected.
Aug 23, 2026 · 12 articles
Tech
United States: The United States is a key country within North American Cobalt Inc., contributing to the region's dominance in the epigenetics market through its strong research infrastructure and leading companies.
Merck Group: Merck Group is listed among the top companies in the epigenetics market, suggesting its involvement and potential for growth within this expanding sector.
Jun 26, 2026 · 6 articles
Domestic
United States: The country faces a public health crisis with falling vaccination rates and a major measles outbreak, exacerbated by this policy.
Merck Group: As a major MMR manufacturer, it faces potential regulatory and market changes. It stated no scientific evidence supports splitting the vaccine, and it may face pressure to develop separate shots.
Aug 10, 2026 · 235 articles
International
United States: US funding cuts under President Trump drove the global decline, though the US still provides 74% of donor funding.
Merck Group: Announced plans to allow generic production of alimatravir, potentially expanding market access.
Jul 21, 2026 · 68 articles
Tech
United States: The US is the primary market for the vaccine, with regulatory approval and patient access being key.
Merck Group: Merck co-developed the vaccine and provided Pembrolizumab, the combination partner. Its shares rose about 10-12%, and the success helps Merck prepare for Pembrolizumab's patent expiration by expanding its cancer portfolio.
Aug 19, 2026 · 102 articles
Accidents
United States: Major donor and also imposed travel restrictions on travelers from DRC, which could hinder aid delivery. Its policies have mixed effects on the response.
Merck Group: Manufacturer of RVSV-ZEBOV vaccine, which is being considered for cross-protection trials. Its vaccine could play a role in the response, benefiting its reputation.
Mar 09, 2018 · 543 articles
Business
United States: The U.S. is Merck's primary market, with vaccine demand declining there, affecting sales of certain vaccines.
Merck Group: Merck is the central company, reporting strong Q2 results and raising revenue guidance. Its stock rose 0.6% in early trading, reflecting positive market reception.
Aug 04, 2026 · 6 articles
Business
United States: The United States economy grew by 2.1% in Q1, and inflation increased, influencing United States — Federal Reserve rate hike expectations and the dollar's strength.
Merck Group: Merck Group agreed to acquire Bio-Techne — Bio-Techne Diagnostics.
Jun 24, 2026 · 57 articles
Regulatory
United States: Partnered with India on semiconductor cooperation (2023 and Pax Silica 2026), supporting India's ecosystem.
Merck Group: Signed an MoU with Tata Group to support semiconductor ecosystem development in India.
Jun 30, 2026 · 69 articles
Business
United States: The United States is mentioned as the regulator that rejected AstraZeneca's breast cancer drug camizestrant, part of the series of setbacks. This regulatory action affects AstraZeneca's US market prospects.
Merck Group: Merck's Keytruda is the comparator in the trial, and the failure of volrustomig may reinforce the competitive position of Keytruda in lung cancer treatment.
Aug 17, 2026 · 20 articles
Business
United States: The United States is the regulatory and market jurisdiction for the IPO, with the SEC and Nasdaq based there.
Merck Group: Merck's Lipfendra, the first FDA-approved PCSK9 pill, represents a competitive threat to Scribe's injectable therapy. Merck's innovation underscores the competitive landscape.
Jul 06, 2026 · 25 articles
Business
United States: Ascentage Pharma has a U.S. presence and FDA clearances, but this event does not directly impact the country.
Merck Group: Merck is a partner of Ascentage Pharma, but this event does not directly involve Merck.
Jul 26, 2026 · 6 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how United States and Merck Group interact across events, view sentiment trends, and discover connected entities.
Open Dashboard